Effects of Abdominal Cushion on PCNL in Prone Position

NCT ID: NCT03797027

Last Updated: 2019-01-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-01

Study Completion Date

2021-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Percutaneous nephrolithotomy (PCNL) is the first choice for the treatment of ≥ 2cm renal stones. The positions of PCNL includes supine, prone and lateral. PCNL has been performed in my center for nearly twenty years. The prone position is routinely used. Generally speaking, an abdominal cushion is used to raise the abdominal in the prone position, in order to provide an adequate exposure of kidney, increase the intercostal space, decrease the mobility of kidney and lower the risk of pleura injury. However, there is no consensus and criterion on the height of abdominal cushion. With largely increased PCNL procedures and various BMI, precise evaluation of abdominal cushion is needed. In the preliminary work, the investigators measured the sunken height of waist of 100 patients in the prone position without a abdominal cushion. The results showed that the mean BMI of 100 patients was 23.45 (16.79-36.98) and the range of sunken height of waist was 2-7 cm. Therefore, the investigators are planning to conduct a randomized controlled study to compare the safety and efficacy among no cushion group, 5 cm cushion group and 10 cm cushion group. To clarify the relationship between height of abdominal cushion and BMI, the nurse could prepare the appropriate cushion the day before surgery, which would decrease operating time and accelerate postoperative recovery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Background Percutaneous nephrolithotomy (PCNL) is the first choice for the treatment of ≥ 2cm renal stones.The positions of PCNL includes supine, prone and lateral. PCNL has been performed in my center for nearly twenty years. The prone position is routinely used. Generally speaking, an abdominal cushion is used to raise the abdominal in the prone position, in order to provide an adequate exposure of kidney, increase the intercostal space, decrease the mobility of kidney and lower the risk of pleura injury. However, there is no consensus and criterion on the height of abdominal cushion. With largely increased PCNL procedures and various BMI, precise evaluation of abdominal cushion is needed. In the preliminary work, the investigators measured the sunken height of waist of 100 patients in the prone position without a abdominal cushion. The results showed that the mean BMI of 100 patients was 23.45 (16.79-36.98) and the range of sunken height of waist was 2-7 cm. Therefore, the investigators are planning to conduct a randomized controlled study to compare the safety and efficacy among no cushion group, 5 cm cushion group and 10 cm cushion group. To clarify the relationship between height of abdominal cushion and BMI, the nurse could prepare the appropriate cushion the day before surgery, which would decrease operating time and accelerate postoperative recovery.
2. Purpose To investigate effects of different height of abdominal cushion on prone PCNL, in terms of intraoperative parameters. Our study could provide high quality of evidences on making criteria of perioperative nurse.
3. Design 3.1 Participant: A single randomized controlled study 3.2 Number of cases: 180 patients who are candidates for PCNL will be enrolled in this study. By 1:2 simple random sampling technique, patients will be assigned to 60-patient no cushion PCNL and 120-patient cushion PCNL (60-patient for 5 cm cushion and 60-patient for 10 cm cushion).

\*(Assuming SFR (1 month after procedure) with cushion PCNL of 90% and expected rate of 70% with no cushion PCNL, the sample size for each group are calculated as 120 and 60 \[power \> 0.90 with a type I error rate \< 0.05.\]
4. Candidate:

4.1 Included criterion:
* Willing to receive PCNL
* Aged 18-70 years
* Normal renal function
* ASA scoreⅠ to Ⅱ 4.2 Excluded criterion:
* Uncorrected coagulopathy and active urinary tract infection (UTI)
* Patients who underwent transplant or urinary diversion.
* Congenital abnormalities. 4.3 Excluded from the study after inclusion Patients will be excluded from the study if the undergoing standard PNL/mini-perc have purulent fluid in the initial puncture.

Patients with positive preoperative urine culture should be treated with suitable antibiotics based on the culture sensitivity result for at least 72 h before PCNL. Patients who have negative urine culture should receive a single dose of broad spectrum antibiotic prophylaxis just prior to the procedure. Patients who are going to receive PCNL would get a envelope including a randomized number and consent letter.
5. Surgical technique

Under general anaesthesia, each patient is initially placed in the lithotomy position, and a 5 Fr or 6Fr ureteral catheter is inserted to the kidney and fixed with a 16 Fr Foley catheter. Then the patient is turned to the prone position. An abdominal cushion is used according to the randomized number. The choice of using C-arm fluoroscopic or ultrasonography guidance or a combination fashion for the percutaneous access was made at the discretion of the treating urologist. The length of the needle from skin to the collecting system is measured to ensure that the length of dilator is appropriate. No patient underwent bilateral simultaneous PCNL and patients with bilateral stones underwent surgery 4 weeks apart. The access tract is dilated with a fascial dilator from 8F up to 18F. The investigators defined access to the collecting system as gaining entry to the targeted urinary system and desired calix. For some complex cases, when indicated requiring multiple tracts, additional tracts were created in the same session. The stone was fragmented by pneumatic lithotripsy or Holmium:YAG laser lithotripsy through 8/9.8F semirigid ureteroscope (Richard Wolf, Germany). The large fragments were extracted with a forceps and small fragments were flushed out with an endoscopic pulsed perfusion pump. A silastic nephrostomy tube was placed at the end of procedure and a 4-6Fr double pigtail ureteral stent was left for 2 weeks after operation. X-ray check for residual stone fragments is also performed at the end of the procedure.

Patients were candidates for the tubeless procedure only when the following strict conditions were met: single percutaneous tract, absence of major perforation of collecting system and bleeding, complete stone clearance assessed by intraoperative nephroscopy and fluoroscopy at the end of the procedure. For a tubeless procedure, the flank was compressed for 5 min. Patient was monitored for postoperative complications.
6. Data collection

Data for the 2 groups -demographic characteristics, time of puncture and dilation, site of target calix, site of access, S.T.O.N.E score, hemoglobin drop, postoperative pain, duration of procedure, hospital stay, cases of tubeless, complications (modified Clavin system), stone clearance (SFR of postoperative day 1 and 1 month follow-up) and the need for auxiliary treatment (for example, re-PCNL, RIRS and ESWL) - are compared.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Stone

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No cushion

Patients in no cushion group undergo prone percutaneous nephrolithotomy without an abdominal cushion

Group Type OTHER

Percutaneous Nephrolithotomy without an abdominal cushion

Intervention Type DEVICE

patients undergo prone PNCL without an abdominal cushion

5 cm cushion

Patients in 5 cm cushion group undergo prone percutaneous nephrolithotomy with an 5 cm abdominal cushion

Group Type OTHER

Percutaneous Nephrolithotomy with an 5 cm abdominal cushion

Intervention Type DEVICE

patients undergo prone PNCL with an 5 cm abdominal cushion

10 cm cushion

Patients in 10 cm cushion group undergo prone percutaneous nephrolithotomy with an 10 cm abdominal cushion

Group Type OTHER

Percutaneous Nephrolithotomy with an 5 cm abdominal cushion

Intervention Type DEVICE

patients undergo prone PNCL with an 10 cm abdominal cushion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous Nephrolithotomy without an abdominal cushion

patients undergo prone PNCL without an abdominal cushion

Intervention Type DEVICE

Percutaneous Nephrolithotomy with an 5 cm abdominal cushion

patients undergo prone PNCL with an 5 cm abdominal cushion

Intervention Type DEVICE

Percutaneous Nephrolithotomy with an 5 cm abdominal cushion

patients undergo prone PNCL with an 10 cm abdominal cushion

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Willing to receive PCNL
* Aged 18-70 years
* Normal renal function
* ASA scoreⅠ to Ⅱ

Exclusion Criteria

* Uncorrected coagulopathy and active urinary tract infection (UTI)
* Patients who underwent transplant or urinary diversion.
* Congenital abnormalities.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The First Affiliated Hospital of Guangzhou Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Guohua Zeng

Vice president

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guohua Zeng, PH.D & MD

Role: PRINCIPAL_INVESTIGATOR

The First Affiliated Hospital of Guangzhou Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guohua Zeng, PH.D & MD

Role: CONTACT

+86 13802916676

Chao Cai, PH.D & MD

Role: CONTACT

+86 13512780911

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Guohua Zeng, Ph.D & MD.

Role: primary

+86 13802916676

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Honglin Sun

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Supine Percutaneous Nephrolithotomy
NCT04869969 COMPLETED PHASE2/PHASE3